Glutamate-induced glioma cell proliferation is prevented by functional expression of the glutamate transporter GLT-1

FEBS Lett. 2008 Jun 11;582(13):1847-52. doi: 10.1016/j.febslet.2008.04.053. Epub 2008 May 12.

Abstract

A tetracycline-dependent inducible system was used to achieve controlled expression of the glutamate transporter 1 (GLT-1) in C6 glioma cells. Non-induced cells show modest glutamate uptake and, in the presence of L-cystine, these cells tend to release substantial amounts of glutamate. Overnight exposure to doxycycline increased D-[3H]-aspartate uptake, reaching similar capacity as observed in cultured astrocytes. Efficient clearance of exogenously applied glutamate was evidenced in these cells, even in the presence of l-cystine. The addition of glutamate (100 microM) to the medium of non-induced cells significantly increased their proliferation rate, an effect that was blocked when the expression of GLT-1 was induced. This suggests that impaired glutamate uptake capacity in glioma cells indirectly contributes to their proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Proliferation*
  • Excitatory Amino Acid Transporter 2 / genetics
  • Excitatory Amino Acid Transporter 2 / metabolism*
  • Glioma / metabolism*
  • Glioma / pathology*
  • Glutamic Acid / metabolism*
  • Glutamic Acid / pharmacology
  • Rats
  • Transfection

Substances

  • Excitatory Amino Acid Transporter 2
  • Glutamic Acid